The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Infections Associated With Tumor Necrosis Factor-α Antagonists
Abstract
Tumor necrosis factor (TNF)-α antagonists are promising therapeutic agents for patients with severe autoimmune and rheumatologic conditions. Unfortunately, their use has been associated with an increased rate of tuberculosis, endemic mycoses, and intracellular bacterial infections. Infliximab, 1 of 3 available drugs in this novel class, appears to be associated with the greatest risk of infection, likely because of its long half-life and induction of monocyte apoptosis. Prospective trials are necessary to determine the exact risk associated with these agents, particularly the newer TNF-α antagonists. More specific TNF-α blockers, which reduce inflammation while maintaining adequate immunity, are needed. In the meantime, a thorough work-up is mandatory for all febrile illness occurring in TNF-α blocker recipients. We present 4 patients who developed severe infections during TNF-α antagonist therapy, review the literature, and discuss current guidelines for surveillance and prophylaxis. Abbreviations: AIDS = acquired immunodeficiency syndrome, FDA = United States Food and Drug Administration, HIV = human immunodeficiency virus, PPD = purified protein derivative, RA = rheumatoid arthritis, TB = tuberculosis, TH1 = T-helper type 1, TNF = tumor necrosis factor, WBC = white blood cell count.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pfeffer, K., Matsuyama, T., Kündig, T. M., Wakeham, A., Kishihara, K., Shahinian, A., Wiegmann, K., Ohashi, P. S., Krönke, M., & Mak, T. W. (1993) · Cell · doi:10.1016/0092-8674(93)90134-c · Cited by 1,677
Cited by
Histoplasmosis: a Clinical and Laboratory Update
Kauffman, C. A. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00027-06 · Cited by 1,200
Dixon, W. G., Watson, K., Lunt, M., Hyrich, K. L., Silman, A. J., & Symmons, D. P. M. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21978 · Cited by 751
Adult-Onset Immunodeficiency in Thailand and Taiwan
Browne, S. K., Burbelo, P. D., Chetchotisakd, P., Suputtamongkol, Y., Kiertiburanakul, S., Shaw, P. A., Kirk, J. L., Jutivorakool, K., Zaman, R., Ding, L., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1111160 · Cited by 550
Anti-Inflammatory Drugs in the 21st Century
Rainsford, K. D. (2007) · Subcellular Biochemistry · doi:10.1007/1-4020-5688-5_1 · Cited by 463
Targeting Robo4-Dependent Slit Signaling to Survive the Cytokine Storm in Sepsis and Influenza
London, N. R., Zhu, W., Bozza, F. A., Smith, M. C. P., Greif, D. M., Sorensen, L. K., Chen, L., Kaminoh, Y., Chan, A. C., Passi, S. F., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3000678 · Cited by 330
Metadata
- Authors
- Crum, N. F., Lederman, E. R., & Wallace, M. R.
- Venue
- Medicine
- Published
- 2005-09
- Volume
- 84
- Issue
- 5
- Pages
- 291-302
- ISSN
- 0025-7974 (ISSN-L)
- OpenAlex
- W2019746317
- Cited by
- 225
- References
- 1
- FWCI
- 14.83
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Infections Associated With Tumor Necrosis Factor-α Antagonists. https://app.cochat.ai/papers/10.1097/01.md.0000180044.19285.9a
- The paper
- Crum, N. F., Lederman, E. R., & Wallace, M. R. (2005). Infections Associated With Tumor Necrosis Factor-α Antagonists. Medicine. https://doi.org/10.1097/01.md.0000180044.19285.9a
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.